Source apportionment of PM_2.5 at IMPROVE monitoring sites within and outside of marine vessel fuel sulfur emissions control areas by Robert A. Kotchenruther (11235072)

“…IMPROVE sites influenced by marine air masses within the NA-ECA showed an annual mean reduction of PM_2.5 from RFO combustion of 79.0% (range, 60.2% to 91.5%) when comparing impacts from the pre-ECA (RFO average 2.7% S) period of 2009–2011 to the ECA 0.1% fuel S period of 2015–2018. …”

Increased astrogliosis at 4 days of recovery observed in the injured SVZ after H/I is decreased by ALK5 inhibition <i>in vivo</i>. by Jennifer M. Bain (252246)

Increased Dietary Intake of Saturated Fatty Acid Heptadecanoic Acid (C17:0) Associated with Decreasing Ferritin and Alleviated Metabolic Syndrome in Dolphins by Stephanie K. Venn-Watson (774138)

“…To assess potential protective factors against metabolic syndrome related to fish diets, fatty acids were compared between two dolphin populations with higher (n = 30, Group A) and lower (n = 19, Group B) mean insulin (11 ± 12 and 2 ± 5 μIU/ml, respectively; <i>P</i> < 0.0001) and their dietary fish. …”

Over-expression of YKL-40 in 76N MECs decreases E-cad and β-casein, but increases MMP-9 expression and cell invasiveness. by Steve Scully (202724)

Body weight, body composition and glucose metabolism data. by Ditte Olsen Lützhøft (10837857)

Clinical evolution at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

SaFi, laboratory, radiology, vaccine status, and inpatient treatment data. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Relationship between a simplified SCOPE score at start of treatment with anakinra and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Adverse pregnancy outcomes recorded among study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of medical discharge at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Quality of Antenatal care and adverse maternal and fetal outcomes. by Seth Amponsah-Tabi (13949142)

Subjects:

Distribution of different levels of quality of antenatal care provided to study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive factors associated with good quality antenatal care. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive characteristics of the study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Clinical outcome at 60 days based on SaFi, anakinra and a simplified SCOPE. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Comorbidities and severity scales at admission for the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

S1 Data - by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of remaining as an inpatient at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of medical discharge at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of remaining as an inpatient at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects: